• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚胺培南体外抗菌药敏试验的暂行解释标准。

Tentative interpretive criteria for in vitro antibacterial susceptibility testing with imipenem.

作者信息

Shungu D L, Cerami A T, Weinberg E, Capizzi T, Gadebusch H H

出版信息

J Clin Microbiol. 1986 Mar;23(3):421-4. doi: 10.1128/jcm.23.3.421-424.1986.

DOI:10.1128/jcm.23.3.421-424.1986
PMID:3514655
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC268666/
Abstract

Imipenem is a member of a new class of highly potent beta-lactam antibiotics, carbapenems, with a very broad antibacterial spectrum. This study was undertaken to determine tentative interpretive criteria for in vitro susceptibility testing with 10-micrograms imipenem disks. A careful examination of the zone diameters and the corresponding MICs for 489 clinical isolates by regression-line analysis and the error rate-bounded classification scheme suggested the following guidelines: greater than or equal to 16 mm with an MIC correlate of less than or equal to 4 micrograms/ml for susceptible, 14 to 15 mm (8 micrograms/ml) for moderately susceptible, and less than or equal to 13 mm (greater than or equal to 16 micrograms/ml) for resistant. Lack of cross-resistance between imipenem and broad-spectrum cephalosporins such as cefotaxime and ceftazidime argues against their use as class disks to predict in vitro susceptibility of bacterial species to carbapenems.

摘要

亚胺培南是一类新型强效β-内酰胺抗生素(碳青霉烯类)的成员,具有非常广泛的抗菌谱。本研究旨在确定用含10微克亚胺培南的纸片进行体外药敏试验的初步解释标准。通过回归线分析和误差率限定分类方案对489株临床分离株的抑菌圈直径和相应的最低抑菌浓度进行仔细检查后,得出以下指导原则:抑菌圈直径大于或等于16毫米且最低抑菌浓度小于或等于4微克/毫升为敏感,14至15毫米(8微克/毫升)为中度敏感,小于或等于13毫米(大于或等于16微克/毫升)为耐药。亚胺培南与广谱头孢菌素(如头孢噻肟和头孢他啶)之间不存在交叉耐药性,这表明它们不能用作类别纸片来预测细菌对碳青霉烯类的体外药敏情况。

相似文献

1
Tentative interpretive criteria for in vitro antibacterial susceptibility testing with imipenem.亚胺培南体外抗菌药敏试验的暂行解释标准。
J Clin Microbiol. 1986 Mar;23(3):421-4. doi: 10.1128/jcm.23.3.421-424.1986.
2
Antibacterial properties of imipenem with special reference to the activity against methicillin-resistant staphylococci, cefotaxime-resistant Enterobacteriaceae and Pseudomonas aeruginosa.
J Antimicrob Chemother. 1986 Dec;18 Suppl E:27-33. doi: 10.1093/jac/18.supplement_e.27.
3
Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.使用美罗培南(10微克)、亚胺培南(10微克)和氨苄西林(2微克和10微克)药敏纸片对流感嗜血杆菌的解释标准进行重新评估。
J Clin Microbiol. 1996 Aug;34(8):1970-4. doi: 10.1128/jcm.34.8.1970-1974.1996.
4
Multicenter in vitro evaluation of SM-7338, a new carbapenem.新型碳青霉烯类药物SM-7338的多中心体外评估
Antimicrob Agents Chemother. 1989 Apr;33(4):562-5. doi: 10.1128/AAC.33.4.562.
5
In-vitro activity of the penem, FCE 22101, and tentative interpretive criteria for disc susceptibility tests.培南类药物FCE 22101的体外活性及纸片药敏试验的初步解释标准。
J Antimicrob Chemother. 1989 Mar;23 Suppl C:17-30. doi: 10.1093/jac/23.suppl_c.17.
6
Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing.头孢噻肟:体外活性及纸片药敏试验的初步解释标准
Antimicrob Agents Chemother. 1980 Jul;18(1):88-93. doi: 10.1128/AAC.18.1.88.
7
Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporin.
Chemioterapia. 1986 Apr;5(2):92-100.
8
[The effect of cefepime on ceftazidime, cefotaxime and imipenem resistant strains of Acinetobacter, Xanthomonas, Pseudomonas, Flavobacterium, Sphingobacterium and on producers of extended spectrum beta-lactamases (ESBL) with resistance transfer].头孢吡肟对头孢他啶、头孢噻肟和亚胺培南耐药的不动杆菌、黄单胞菌、假单胞菌、黄杆菌、鞘氨醇杆菌菌株以及对具有耐药性转移的超广谱β-内酰胺酶(ESBL)产生菌的影响
Cas Lek Cesk. 1997 Mar 12;136(5):154-6.
9
Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks.
Diagn Microbiol Infect Dis. 1983 Dec;1(4):295-311. doi: 10.1016/0732-8893(83)90005-6.
10
Thienamycin: development of imipenen-cilastatin.硫霉素:亚胺培南-西司他丁的研发
J Antimicrob Chemother. 1983 Dec;12 Suppl D:1-35. doi: 10.1093/jac/12.suppl_d.1.

引用本文的文献

1
Endophthalmitis caused by Enterococcus mundtii.蒙氏肠球菌引起的眼内炎。
J Clin Microbiol. 2005 Mar;43(3):1475-6. doi: 10.1128/JCM.43.3.1475-1476.2005.
2
Multicenter evaluation of use of penicillin and ampicillin as surrogates for in vitro testing of susceptibility of enterococci to imipenem.以青霉素和氨苄西林作为替代物对肠球菌进行亚胺培南体外药敏试验的多中心评估。
J Clin Microbiol. 2004 Aug;42(8):3747-51. doi: 10.1128/JCM.42.8.3747-3751.2004.
3
Prediction of enterococcal imipenem susceptibility using ampicillin or penicillin MICs: more evidence for a class concept.使用氨苄西林或青霉素的最低抑菌浓度预测肠球菌对亚胺培南的敏感性:关于类别概念的更多证据
J Clin Microbiol. 2001 Oct;39(10):3810-1. doi: 10.1128/JCM.39.10.3810-3811.2001.
4
Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.对万古霉素敏感和耐药的粪肠球菌和屎肠球菌,青霉素、氨苄西林和亚胺培南的最低抑菌浓度(MIC)及药敏折点的比较评估
J Clin Microbiol. 2001 Jul;39(7):2729-31. doi: 10.1128/JCM.39.7.2729-2731.2001.

本文引用的文献

1
The plasma pharmacokinetics of high dose (1 g) imipenem coadministered with 1 g cilastatin in six normal volunteers.在六名正常志愿者中,高剂量(1克)亚胺培南与1克西司他丁联合使用时的血浆药代动力学。
Eur J Clin Microbiol. 1984 Oct;3(5):468-70. doi: 10.1007/BF02017377.
2
Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors.N-甲酰亚胺基硫霉素脱氢肽酶抑制剂共同给药对N-甲酰亚胺基硫霉素(MK0787)尿回收率的影响
Antimicrob Agents Chemother. 1983 Feb;23(2):300-7. doi: 10.1128/AAC.23.2.300.
3
Interpretive standards and quality control guidelines for imipenem susceptibility tests with 10-micrograms disks.使用10微克纸片进行亚胺培南药敏试验的解释标准和质量控制指南。
J Clin Microbiol. 1984 Nov;20(5):988-9. doi: 10.1128/jcm.20.5.988-989.1984.
4
In vitro activity of imipenem--a review.亚胺培南的体外活性——综述
Eur J Clin Microbiol. 1984 Oct;3(5):456-62. doi: 10.1007/BF02017375.
5
Thienamycin: development of imipenen-cilastatin.硫霉素:亚胺培南-西司他丁的研发
J Antimicrob Chemother. 1983 Dec;12 Suppl D:1-35. doi: 10.1093/jac/12.suppl_d.1.
6
In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.与头孢噻肟、拉氧头孢和头孢他啶相比,N-甲酰亚胺硫霉素的体外活性。
Antimicrob Agents Chemother. 1981 Mar;19(3):402-6. doi: 10.1128/AAC.19.3.402.
7
Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits.头孢哌酮纸片扩散法药敏试验:暂定解释标准的确认、铜绿假单胞菌交叉耐药性及质量控制性能限度的测定
J Clin Microbiol. 1982 May;15(5):777-86. doi: 10.1128/jcm.15.5.777-786.1982.
8
Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.厌氧菌药敏试验:统计学与临床考量
J Infect Dis. 1974 Dec;130(6):588-94. doi: 10.1093/infdis/130.6.588.
9
Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin.碳青霉烯类,一类新型β-内酰胺抗生素。亚胺培南/西司他丁的发现与研发。
Am J Med. 1985 Jun 7;78(6A):3-21. doi: 10.1016/0002-9343(85)90097-x.